Mass Tort Marketing Agency

NEC cost per signed retainer

NEC (necrotizing enterocolitis, cow's milk formula) carries a cost per signed retainer of $3,100–$4,800 in Q1 2026, current as of March 31, 2026, at an 8–13% signed rate and a high qualification tier. Litigation status (verified November 17, 2026): active federal mdl. Sample size and confidence interval for this row are not available; the reason is stated on each figure below rather than omitted.

Data as of Updated Q1 2026 releaseLatest published release; the next quarterly release has not been published yet

NEC litigation status & sources

Active federal MDL

Status verified on against primary sources · next check due

As of Nov 2026, MDL 3026 (N.D. Ill.) over preterm infant formula and NEC has 847 pending actions. The first federal bellwether to reach a jury ended in a defense verdict for Mead Johnson in Aug 2026; state-court cases continue separately.

Proceeding
MDL 3026 (Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation) (N.D. Ill.)
Rebecca R. Pallmeyer
Pending actions
847
JPML Pending MDL Dockets by District, report date 2026-11-02

Key dates

  1. A federal jury returned a defense verdict for Mead Johnson in the Inman bellwether, the first MDL 3026 case tried to verdict (trial began Aug 17, 2026).

Sources

Marketing information for law firms, not legal advice. Litigation status changes; confirm filing posture, case criteria and deadlines with counsel before launching or continuing a campaign. How we source and date this: editorial standards.

CPR range · Q1 2026

$3,100 – $4,800

Median: n/a — Per-tort medians are not published. The dataset carries the interquartile low and high bounds for each tort; only the national median is published as a point value.

Signed rate

8–13%

Share of exclusive leads that become signed retainers.

Qualification tier

High

Relative difficulty of clearing this tort's qualifying criteria.

Litigation status

Active federal MDL

Verified November 17, 2026 against primary sources.

Sample size

n/a

Per-tort sample sizes are not broken out in the published dataset. The panel total (140 firms, $180M of annual mass tort lead spend across 16 active tort categories) is published at the panel level only, so the number of firms and the spend basis behind any single row cannot be stated.

Confidence interval

n/a

Not computable from the published dataset. Benchmarks are published as trimmed interquartile ranges, and the per-observation values a confidence interval requires are not retained in the published figures.

Verification status

Unverified

No third party has reviewed this methodology or the underlying data. Mass Tort Marketing Agency sells the leads these figures price.

What third-party verification would involve

NEC CPR over time

The series for NEC starts at Q1 2026. Mass Tort Marketing Agency holds one published quarter of per-tort data for this tort, so there is no trend line to draw yet — the single point is shown below, and a second point will appear when the next quarter publishes.

NEC (necrotizing enterocolitis, cow's milk formula) cost per signed retainer by quarter, in USD.
QuarterCPR lowCPR highNote
Q4 2024n/an/aNo per-tort breakdown for Q4 2024 is held in the dataset. Only the national median is held for that quarter, which is why the per-tort trend series begins at Q1 2026.
Q1 2026$3,100$4,800Published.

What qualifies a NEC claimant

A premature infant received Similac or Enfamil cow's-milk-based formula (not breast milk or human-milk-based formula) during a specific neonatal window, and was subsequently diagnosed with necrotizing enterocolitis.

Falloff: 28–35%. This is the qualification-failure rate at medical-record review — the share of signed retainers that fail to file — and is the highest of any active tort.

Active — what that means for acquisition

Active, with among the most technically specific criteria of any active tort. Roughly 28-35% of signed retainers fail to file because documentation of formula brand, formula batch, or gestational age cannot be produced. Firms running Tier-2 medical-record pre-screening within 72 hours of initial retainer cut filed-case falloff to 12-18%; a 20-point reduction drops effective CPR from the upper-band $4,800 to roughly $3,400.

NEC cost per lead

This dataset does not publish a cost-per-lead figure for NEC, and no CPL value is shown here rather than being derived from the CPR band. The two are related by the signed rate — CPL is approximately CPR × signed rate — but running that multiplication against a published interquartile band produces a number that looks measured and is not, so it is left out. What the benchmark does state is the signed rate: 8–13% of exclusive NEC leads become signed retainers that survive the 30-day falloff window. If you have your own CPL from a vendor quote, that signed rate is the multiplier that turns it into a comparable CPR.

Download this row

Download CSVView JSONExports of the NEC row, generated from the same file the page renders.

How to cite this page

Suggested citation:

Mass Tort Marketing Agency. "NEC (necrotizing enterocolitis, cow's milk formula) cost per signed retainer." Q1 2026 CPR Benchmark, published April 24, 2026. https://www.masstortmarketingagency.com/benchmarks/nec-baby-formula

Canonical URL:
https://www.masstortmarketingagency.com/benchmarks/nec-baby-formula
License:
CC BY 4.0 — reuse permitted with attribution to Mass Tort Marketing Agency CPR Benchmark, https://www.masstortmarketingagency.com/benchmarks/

Citing a number that must stay stable? Point at a dated snapshot instead of the live page — snapshot files never change.